Travere Therapeutics Stock (NASDAQ:TVTX), Quotes and News Summary

Q: What sector and industry does Travere Therapeutics (TVTX) operate in?

Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Travere Therapeutics Stock (NASDAQ: TVTX) stock price, news, charts, stock research, profile.

Open	$5.780
Close	$5.450
Volume / Avg.	2.778M / 1.174M
Day Range	5.340 - 5.780
52 Wk Range	5.250 - 22.750
Market Cap	$418.599M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	24
Short Interest	15.67%
Days to Cover	10.73

Recent News

Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug

The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) at

Vandana Singh

THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday.

Lisa Levin

Crude Oil Moves Lower; AutoZone Profit Tops Views

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500 also fell, dropping, 0.07% to 4,566.73.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Travere Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, deve...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Travere Therapeutics (TVTX) stock?

You can purchase shares of Travere Therapeutics (NASDAQ: TVTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Travere Therapeutics's (TVTX) competitors?

Other companies in Travere Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Replimune Group (NASDAQ:REPL).

What is the target price for Travere Therapeutics (TVTX) stock?

The latest price target for Travere Therapeutics (NASDAQ: TVTX) was reported by HC Wainwright & Co. on Wednesday, April 24, 2024. The analyst firm set a price target for 19.00 expecting TVTX to rise to within 12 months (a possible 245.45% upside). 36 analyst firms have reported ratings in the last year.

Current Stock Price for Travere Therapeutics (TVTX)?

The stock price for Travere Therapeutics (NASDAQ: TVTX) is $5.5 last updated Today at April 24, 2024 at 4:22 PM EDT.

Does Travere Therapeutics (TVTX) pay a dividend?

There are no upcoming dividends for Travere Therapeutics.

When is Travere Therapeutics (NASDAQ:TVTX) reporting earnings?

Travere Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is Travere Therapeutics (TVTX) going to split?

There is no upcoming split for Travere Therapeutics.

What sector and industry does Travere Therapeutics (TVTX) operate in?

Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-